To examine the role of DAPK1 in the cell cycle, with a particular focus on cervical cancer cells, asynchronously growing HeLa cells with high DAPK1 expression were treated with different agents (thymidine, nocodazole, RO-3306) for synchronization. This evidence concerns the gene DAPK1 and cervical carcinoma.